Skip to content

AS ENDURO NB015ZRecalls & reported problems

Aesculap AG · AS ENDURO FEMORAL COMPONENT CEMENTED F2L · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04046963177492), received between Jul 14, 2021 and Jul 14, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Loosening of Implant Not Related to Bone-Ingrowth1

Patient problems

  • Failure of Implant1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 14, 2021Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth

    INVOLVED COMPONENTS: NR400Z - AS NUT F/FEMUR EXTENS.STEM ALL SZ.NEUTR. - LOT 52211649; NR194Z - AS TIBIA OFFSET STEM D12X92MM CEMENTED - LOT 52257685; NR865Z - AS ENDURO FEMUR SPACER DISTAL F2 8MM - LOT 52287175; NR865Z - AS ENDURO FEMUR SPACER DISTAL F2 8MM - LOT 51905538; NR292Z - AS FEMUR EXTENS.STEM 6° D15X77 CEMENTED - LOT 52295198; NR884Z - AS ENDURO MENISCAL COMPONENT F2 18MM - LOT 52318309; NB011Z - AS ENDURO TIBIAL COMP.OFFSET CEMENTED T1 - LOT 52328619.

    Patient problems: Failure of Implant

    MAUDE report 12167184 ↗

Other PROSTHESIS, KNEE, FEMOROTIBIAL, CONSTRAINED, CEMENTED, METAL/POLYMER devices

All PROSTHESIS, KNEE, FEMOROTIBIAL, CONSTRAINED, CEMENTED, METAL/POLYMER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page